Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Not sure I like this part...
Only because there were actual payments in the quarter that they did know of and there also may have been a "token" payment in the 3rd quarter by the J's too...and as long as PTSC does not reveal into the public domain the actual revenues and particulars of the agreements received from licenses they will always be restricted from buying shares till the Q is published...IMO
Share
New Message
Please login to post a reply